Complement C3b contributes to


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 16 08 2022
accepted: 28 11 2022
entrez: 2 1 2023
pubmed: 3 1 2023
medline: 4 1 2023
Statut: epublish

Résumé

Platelets have essential functions as first responders in the immune response to pathogens. Activation and aggregation of platelets in bacterial infections can lead to life-threatening conditions such as arterial thromboembolism or sepsis-associated coagulopathy. In this study, we investigated the role of complement in We found that compstatin, which inhibits the cleavage of complement component C3 to its components C3a and C3b, reduced the

Identifiants

pubmed: 36591264
doi: 10.3389/fimmu.2022.1020712
pmc: PMC9797026
doi:

Substances chimiques

Complement C3b 80295-43-8
Hirudins 0
Platelet Glycoprotein GPIIb-IIIa Complex 0
CR1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1020712

Informations de copyright

Copyright © 2022 Landsem, Emblem, Lau, Christiansen, Gerogianni, Karlsen, Mollnes, Nilsson and Brekke.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Sci Rep. 2018 Nov 1;8(1):16145
pubmed: 30385858
Atherosclerosis. 2015 Feb;238(2):289-95
pubmed: 25544179
J Thromb Haemost. 2016 Nov;14(11):2241-2252
pubmed: 27590476
J Immunol. 1987 Jan 1;138(1):254-8
pubmed: 2946777
Semin Immunopathol. 2021 Dec;43(6):757-771
pubmed: 34698894
Int J Mol Sci. 2022 May 27;23(11):
pubmed: 35682700
Front Immunol. 2019 Jul 26;10:1731
pubmed: 31402914
Clin Chem. 2016 Mar;62(3):525-34
pubmed: 26797686
J Immunol. 2010 Mar 1;184(5):2686-92
pubmed: 20139276
Blood. 1997 Jun 1;89(11):4047-57
pubmed: 9166844
Blood. 2002 Sep 1;100(5):1869-77
pubmed: 12176911
Platelets. 2016 Sep;27(6):535-40
pubmed: 27025455
J Exp Med. 1983 Aug 1;158(2):603-15
pubmed: 6604123
Blood. 2017 Apr 20;129(16):2291-2302
pubmed: 28223279
Semin Immunol. 2016 Dec;28(6):561-569
pubmed: 27866916
Platelets. 2018 Nov;29(7):670-676
pubmed: 29799301
Platelets. 2021 Apr 3;32(3):314-324
pubmed: 32896192
Blood Rev. 2018 Jul;32(4):280-288
pubmed: 29397262
Nat Rev Immunol. 2013 Jan;13(1):34-45
pubmed: 23222502
PLoS One. 2018 Jan 31;13(1):e0192051
pubmed: 29385206
PLoS One. 2010 Sep 23;5(9):e12889
pubmed: 20886107
Immunol Cell Biol. 2016 Sep;94(8):787-95
pubmed: 27108698
J Exp Med. 1983 Aug 1;158(2):334-52
pubmed: 6224880
J Exp Med. 2005 Mar 21;201(6):871-9
pubmed: 15781579
J Immunol. 1985 Apr;134(4):2580-7
pubmed: 3156186
Nat Immunol. 2011 Oct 30;12(12):1194-201
pubmed: 22037602
Semin Immunol. 2018 Jun;37:43-52
pubmed: 29426568
Methods Mol Biol. 2004;272:13-28
pubmed: 15226531
Blood. 2010 Mar 18;115(11):2283-91
pubmed: 20068220
Immunol Cell Biol. 1987 Dec;65 ( Pt 6):453-60
pubmed: 2966106
Blood. 1988 Apr;71(4):831-43
pubmed: 2833328
Haematologica. 2021 Jun 01;106(6):1616-1623
pubmed: 32354869
J Thromb Haemost. 2011 Jun;9(6):1097-107
pubmed: 21435167
Cell Commun Signal. 2016 Aug 11;14(1):16
pubmed: 27515066
J Thromb Haemost. 2016 Apr;14(4):797-806
pubmed: 26669970
Nat Rev Drug Discov. 2015 Dec;14(12):857-77
pubmed: 26493766
Platelets. 2018 Jan;29(1):21-26
pubmed: 28643541
Cells. 2022 Mar 25;11(7):
pubmed: 35406684
Pharmacol Rev. 2021 Apr;73(2):792-827
pubmed: 33687995
J Thromb Haemost. 2019 Feb;17(2):271-282
pubmed: 30618125
Am J Pathol. 1971 Nov;65(2):367-80
pubmed: 4400052
J Leukoc Biol. 2007 Jun;81(6):1404-13
pubmed: 17389579
MAbs. 2020 Jan-Dec;12(1):1686319
pubmed: 31671278
Mol Immunol. 2011 Sep;48(15-16):2159-69
pubmed: 21839519
Immunochemistry. 1977 Jan;14(1):25-30
pubmed: 849874
Front Immunol. 2019 Aug 06;10:1748
pubmed: 31447831
Nat Rev Immunol. 2020 Oct;20(10):633-643
pubmed: 32782358
Arch Dis Child. 2002 Jan;86(1):44-6
pubmed: 11806883
Blood. 2002 Jun 1;99(11):3978-84
pubmed: 12010797
Blood. 2010 Aug 12;116(6):1002-10
pubmed: 20466856
Nat Rev Microbiol. 2006 Jun;4(6):445-57
pubmed: 16710325
J Clin Microbiol. 1987 Nov;25(11):2181-8
pubmed: 3320085
Circulation. 2018 Oct 16;138(16):1720-1735
pubmed: 29802205
J Immunol. 2013 Nov 1;191(9):4769-77
pubmed: 24062486
Eur J Immunol. 1991 Feb;21(2):343-9
pubmed: 1999223
Front Immunol. 2019 Jul 10;10:1590
pubmed: 31354729
Front Immunol. 2019 Jul 17;10:1687
pubmed: 31379873

Auteurs

Anne Landsem (A)

Research Laboratory and Department of Laboratory Medicine, Nordland Hospital Trust, Bodø, Norway.

Åse Emblem (Å)

Research Laboratory and Department of Laboratory Medicine, Nordland Hospital Trust, Bodø, Norway.

Corinna Lau (C)

Research Laboratory and Department of Laboratory Medicine, Nordland Hospital Trust, Bodø, Norway.

Dorte Christiansen (D)

Research Laboratory and Department of Laboratory Medicine, Nordland Hospital Trust, Bodø, Norway.

Alexandra Gerogianni (A)

Linnaeus Centre for Biomaterials Chemistry, Linnaeus University, Kalmar, Sweden.
Department of Chemistry and Biomedicine, Linnaeus University, Kalmar, Sweden.

Bård Ove Karlsen (BO)

Research Laboratory and Department of Laboratory Medicine, Nordland Hospital Trust, Bodø, Norway.

Tom Eirik Mollnes (TE)

Research Laboratory and Department of Laboratory Medicine, Nordland Hospital Trust, Bodø, Norway.
Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Immunology, Oslo University Hospital, University of Oslo, Oslo, Norway.

Per H Nilsson (PH)

Linnaeus Centre for Biomaterials Chemistry, Linnaeus University, Kalmar, Sweden.
Department of Chemistry and Biomedicine, Linnaeus University, Kalmar, Sweden.
Department of Immunology, Oslo University Hospital, University of Oslo, Oslo, Norway.

Ole-Lars Brekke (OL)

Research Laboratory and Department of Laboratory Medicine, Nordland Hospital Trust, Bodø, Norway.
Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH